Heartland Hospice Serving South Florida

If hospice patients need care beyond what can be provided at home, the VITAS inpatient hospice unit is designed to provide necessary and appropriate care. The staff—physician, registered nurse, social worker, chaplain, volunteer, bereavement specialist, team manager—focus on bringing your symptom...

Miguel A. Medina III, M.D., is a plastic and reconstructive surgeon and director of microsurgery at Miami Cancer Institute at Baptist Health South Florida. Dr. Medina specializes in complex reconstruction and microsurgery, utilizing specialized operating microscopes and precision instrumentation to perform intricate procedures such as the reconnection of nerves, muscles and blood vessels. He focuses on restoring physical function and appearance as well as confidence and dignity after the surgical treatment of cancer.Board certified by the American Board of Plastic Surgery, Dr. Medina’s clinical focus includes abdominal wall reconstruction, breast reconstructive surgery including DIEP flap reconstruction, craniofacial reconstruction and head and neck reconstructive surgery. He earned his medical degree from the University of North Carolina School of Medicine in Chapel Hill, N.C. He completed a surgery residency at Massachusetts General Hospital, Harvard Medical School in Boston, Mass., receiving the V.H. Kazanjian Research Fellowship in reconstructive surgery. He also completed a plastic surgery residency in the Harvard Plastic Surgery Program at Harvard Medical School, where he served as chief resident. He continued his postdoctoral training with a fellowship in craniofacial surgery and microsurgery at The Johns Hopkins Hospital/R Adams Cowley Shock Trauma Center, Johns Hopkins School of Medicine in Baltimore, Md. Prior to joining Miami Cancer Institute, Dr. Medina specialized in craniofacial and reconstructive microsurgery at Cleveland Clinic in Weston, Fla. He is an innovator in his field, with numerous invited national and international presentations, instructional courses and lectures. He also is a distinguished clinical educator, serving as clinical assistant professor of surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Dr. Medina has authored numerous peer-reviewed articles and book chapters and serves as a reviewer for three scientific journals, including the Journal of Plastic, Reconstructive, and Aesthetic Surgery. He is fluent in English and Spanish.

Minesh Mehta, M.D., is chief of radiation oncology and deputy director of Baptist Health Miami Cancer Institute and a widely renowned expert in radiation oncology, proton therapy and cancer research. Dr. Mehta received his medical degree with highest honors from the University of Zambia School of Medicine. He completed a residency at the University of Wisconsin, where he was later appointed chairman of the medical school’s Department of Human Oncology.As part of his leadership efforts, he directed research studies, technology development and the expansion at the University of Wisconsin Cancer Center. He also headed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trial research. Dr. Mehta has designed and led numerous national and international clinical studies, receiving National Institutes of Health and National Cancer Institute grants and winning honors for his research in brain and central nervous system tumors. He helped launch and was the medical director of the Maryland Proton Treatment Center in Baltimore, prior to joining Baptist Health. He is board-certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties. He has held national leadership positions in numerous organizations including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology and the Society of Neuro-Oncology.An avid researcher, Dr. Mehta provides a multidisciplinary, innovative approach to individual care and helps all his patients understand their diagnosis, available treatment options and potential clinical trials.